{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:03Z","timestamp":1791932403530,"version":"4.3.4"},"reference-count":49,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Ebola virus (EBOV) is a highly lethal pathogen that has caused several outbreaks of severe hemorrhagic fever in humans since its emergence in 1976. The EBOV glycoprotein (GP1,2) is the sole viral envelope protein and a major component of immunogenicity; it is encoded by the GP gene along with two truncated versions: soluble GP (sGP) and small soluble GP (ssGP). sGP is, in fact, the primary product of the GP gene, and it is secreted in abundance during EBOV infection. Since sGP shares large portions of its sequence with GP1,2, it has been hypothesized that sGP may subvert the host immune response by inducing antibodies against sGP rather than GP1,2. Several reports have shown that sGP plays multiple roles that contribute to the complex pathogenesis of EBOV. In this review, we focus on sGP and discuss its possible roles with regards to the pathogenesis of EBOV and the development of specific antiviral drugs.<\/jats:p>","DOI":"10.3390\/v11110999","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T06:33:29Z","timestamp":1572503609000},"page":"999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-9891","authenticated-orcid":false,"given":"Wenjun","family":"Zhu","sequence":"first","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Banadyga","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Emeterio","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[{"name":"Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China"},{"name":"D\u00e9partement de microbiologie-infectiologie et d\u2019immunologie, Universit\u00e9 Laval, Qu\u00e9bec, QC G1V 0A6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangguo","family":"Qiu","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/jgv.0.001252","article-title":"ICTV Virus Taxonomy Profile: Filoviridae","volume":"100","author":"Kuhn","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3201\/eid2505.181666","article-title":"Bombali Virus in Mops condylurus Bat, Kenya","volume":"25","author":"Forbes","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The Pathogenesis of Ebola Virus Disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"ref_4","unstructured":"Feldmann, H., Sanchez, A., and Geisbert, T.W. (2013). Fields Virology. Filoviridae: Marburg and Ebola Viruses, Wolters Kluwer. Chapter 32."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMp1413084","article-title":"Ebola virus disease in West Africa\u2014Clinical manifestations and management","volume":"371","author":"Chertow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/cid\/civ606","article-title":"Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement","volume":"61","author":"Sagui","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","first-page":"381","article-title":"Filovirus Structural Biology: The Molecules in the Machine","volume":"411","author":"Kirchdoerfer","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_9","first-page":"323","article-title":"Mechanisms of Filovirus Entry","volume":"411","author":"Davey","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S897","DOI":"10.1093\/infdis\/jir313","article-title":"sGP serves as a structural protein in Ebola virus infection","volume":"204","author":"Iwasa","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1126\/science.1057269","article-title":"Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity","volume":"291","author":"Volchkov","year":"2001","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/infdis\/jiv309","article-title":"RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor","volume":"212","author":"Volchkova","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16128","DOI":"10.1038\/nmicrobiol.2016.128","article-title":"Structures of Ebola virus GP and sGP in complex with therapeutic antibodies","volume":"1","author":"Pallesen","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","article-title":"Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function","volume":"79","author":"Afanasieva","year":"2005","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2014.0068","article-title":"The multiple roles of sGP in Ebola pathogenesis","volume":"28","author":"Wong","year":"2015","journal-title":"Viral. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.3390\/v7102867","article-title":"Filoviruses: One of These Things is (not) Like the Other","volume":"7","author":"Anthony","year":"2015","journal-title":"Viruses"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cook, J.D., and Lee, J.E. (2013). The secret life of viral entry glycoproteins: Moonlighting in immune evasion. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003258"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","article-title":"Ectodomain shedding of the glycoprotein GP of Ebola virus","volume":"23","author":"Dolnik","year":"2004","journal-title":"EMBO J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JVI.01462-09","article-title":"Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1","volume":"84","author":"Okumura","year":"2010","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Escudero-Perez, B., Volchkova, V.A., Dolnik, O., Lawrence, P., and Volchkov, V.E. (2014). Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004509"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/viro.1999.0034","article-title":"Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus","volume":"265","author":"Volchkova","year":"1999","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/viro.1998.9389","article-title":"The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer","volume":"250","author":"Volchkova","year":"1998","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S941","DOI":"10.1093\/infdis\/jir321","article-title":"Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs","volume":"204","author":"Volchkova","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/infdis\/jiu681","article-title":"An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity","volume":"212","author":"Tsuda","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1093\/infdis\/jiv111","article-title":"Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs","volume":"212","author":"Hoenen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2018.01.008","article-title":"Ebola Virus Persistence Study, G., Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors","volume":"22","author":"Whitmer","year":"2018","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.164.2.953","article-title":"Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils","volume":"164","author":"Kindzelskii","year":"2000","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellimm.2017.11.009","article-title":"Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses","volume":"324","author":"Bradley","year":"2018","journal-title":"Cell Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mohan, G.S., Li, W., Ye, L., Compans, R.W., and Yang, C. (2012). Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003065"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2007.02.004","article-title":"Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens","volume":"143","author":"Shahhosseini","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JVI.02098-06","article-title":"Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines","volume":"81","author":"Dowling","year":"2007","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JVI.00101-16","article-title":"Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies","volume":"90","author":"Ilinykh","year":"2016","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1093\/infdis\/jiy267","article-title":"Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge","volume":"218","author":"Liu","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Viral Hemorrhagic Fever Immunotherapeutic, C., Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gunn, B.M., Roy, V., Karim, M.M., Hartnett, J.N., Suscovich, T.J., Goba, A., Momoh, M., Sandi, J.D., Kanneh, L., and Andersen, K.G. (2019). Survivors of Ebola virus disease develop polyfunctional antibody responses. J. Infect. Dis.","DOI":"10.1093\/infdis\/jiz364"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E7578","DOI":"10.1073\/pnas.1806200115","article-title":"Analysis of CD8(+) T cell response during the 2013-2016 Ebola epidemic in West Africa","volume":"115","author":"Sakabe","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1128\/JVI.02600-10","article-title":"Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry","volume":"85","author":"Radoshitzky","year":"2011","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/v7010285","article-title":"Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif","volume":"7","author":"Gallaher","year":"2015","journal-title":"Viruses"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"He, J., Melnik, L.I., Komin, A., Wiedman, G., Fuselier, T., Morris, C.F., Starr, C.G., Searson, P.C., Gallaher, W.R., and Hristova, K. (2017). Ebola Virus Delta Peptide Is a Viroporin. J. Virol., 91.","DOI":"10.1128\/JVI.00438-17"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1099\/0022-1317-82-12-2839","article-title":"Biosynthesis and role of filoviral glycoproteins","volume":"82","author":"Feldmann","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41579-019-0233-2","article-title":"Therapeutic strategies to target the Ebola virus life cycle","volume":"17","author":"Hoenen","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"l5371","DOI":"10.1136\/bmj.l5371","article-title":"New treatments for Ebola virus disease","volume":"366","author":"Lucey","year":"2019","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2015.01.002","article-title":"Ebola virus disease in Africa: Epidemiology and nosocomial transmission","volume":"90","author":"Shears","year":"2015","journal-title":"J. Hosp. Infect."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/11\/999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:44Z","timestamp":1760189444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/11\/999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["v11110999"],"URL":"https:\/\/doi.org\/10.3390\/v11110999","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}